Background and objective Enterobacteriaceae (EB) spp. family is known to include potentially multidrug-resistant (MDR) microorganisms, and remains as an important cause of community-acquired pneumonia (CAP) associated with high mortality. The aim of this study was to determine the prevalence and specific risk factors associated with EB and MDR-EB in a cohort of hospitalized adults with CAP. Methods We performed a multinational, point-prevalence study of adult patients hospitalized with CAP. MDR-EB was defined when >= 3 antimicrobial classes were identified as non-susceptible. Risk factors assessment was also performed for patients with EB and MDR-EB infection. Results Of the 3193 patients enrolled with CAP, 197 (6%) had a positive culture with EB. Fifty-one percent (n = 100) of EB were resistant to at least one antibiotic and 19% (n = 38) had MDR-EB. The most commonly EB identified were Klebsiella pneumoniae (n = 111, 56%) and Escherichia coli (n = 56, 28%). The risk factors that were independently associated with EB CAP were male gender, severe CAP, underweight (body mass index (BMI) < 18.5) and prior extended-spectrum beta-lactamase (ESBL) infection. Additionally, prior ESBL infection, being underweight, cardiovascular diseases and hospitalization in the last 12 months were independently associated with MDR-EB CAP. Conclusion This study of adults hospitalized with CAP found a prevalence of EB of 6% and MDR-EB of 1.2%, respectively. The presence of specific risk factors, such as prior ESBL infection and being underweight, should raise the clinical suspicion for EB and MDR-EB in patients hospitalized with CAP.
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia / D. Villafuerte, S. Aliberti, N.J. Soni, P. Faverio, P.J. Marcos, R.G. Wunderink, A. Rodriguez, O. Sibila, F. Sanz, I. Martin-Loeches, F. Menzella, L.F. Reyes, M. Jankovic, M. Spielmanns, M.I. Restrepo, P.K. Aruj, S. Attorri, E. Barimboim, J.P. Caeiro, M.I. Garzon, V.H. Cambursano, A. Ceccato, J. Chertcoff, A. Cordon Diaz, L. de Vedia, M.C. Ganaha, S. Lambert, G. Lopardo, C.M. Luna, A.G. Malberti, N. Morcillo, S. Tartara, C. Pensotti, B. Pereyra, P.G. Scapellato, J.P. Stagnaro, S. Shah, F. Lotsch, F. Thalhammer, K. Anseeuw, C.A. Francois, E. Van Braeckel, J.L. Vincent, M.Z. Djimon, S.A. Nouer, P. Chipev, M. Encheva, D. Miteva, D. Petkova, A.D. Balkissou, E.W.P. Yone, B.H.M. Ngahane, N. Shen, J.-. Xu, C.A.B. Rico, R. Buitrago, F.J.P. Paternina, J.-.K. Ntumba, V.V. Carevic, M. Jakopovic, M. Jankovic, Z. Matkovic, I. Mitrecic, M.-.B. Jacobsson, A.B. Christensen, U.C. Heitmann Bodtger, C.N. Meyer, A.V. Jensen, I. El-Said Abd El-Wahhab, N.E. Morsy, H. Shafiek, E. Sobh, K.A. Abdulsemed, F. Bertrand, C. Brun-Buisson, E.D. Montmollin, M. Fartoukh, J. Messika, P. Tattevin, A. Khoury, B. Ebruke, M. Dreher, M. Kolditz, M. Meisinger, M.W. Pletz, S. Hagel, J. Rupp, T. Schaberg, M. Spielmanns, P. Creutz, N. Suttorp, B. Siaw-Lartey, K. Dimakou, D. Papapetrou, E. Tsigou, D. Ampazis, E. Kaimakamis, M. Bhatia, R. Dhar, G. D'Souza, R. Garg, P.A. Koul, P.A. Mahesh, B.S. Jayaraj, K.V. Narayan, H.B. Udnur, S.B. Krishnamurthy, S. Kant, R. Swarnakar, S. Limaye, S. Salvi, K. Golshani, V.M. Keatings, I. Martin-Loeches, Y. Maor, J. Strahilevitz, S. Battaglia, M. Carrabba, P. Ceriana, M. Confalonieri, A.D. Monforte, B.D. Prato, M.D. Rosa, R. Fantini, G. Fiorentino, M.A. Gammino, F. Menzella, G. Milani, S. Nava, G. Palmiero, R. Petrino, B. Gabrielli, P. Rossi, C. Sorino, G. Steinhilber, A. Zanforlin, F. Franzetti, M. Carone, V. Patella, S. Scarlata, A. Comel, K. Kurahashi, Z.A. Bacha, D.B. Ugalde, O.C. Zuniga, J.F. Villegas, M. Medenica, E.M.W. van de Garde, D.R. Mihsra, P. Shrestha, E. Ridgeon, B.I. Awokola, O.N.O. Nwankwo, A.B. Olufunlola, S. Olumide, K.N. Ukwaja, M. Irfan, L. Minarowski, S. Szymon, F. Froes, P. Leuschner, M. Meireles, S.B. Ravara, V. Brocovschii, C. Ion, D. Rusu, C. Toma, D. Chirita, C.M. Dorobat, A. Birkun, A. Kaluzhenina, A. Almotairi, Z.A.A. Bukhary, J. Edathodu, A. Fathy, A.M.A. Enani, N.E. Mohamed, J.U. Memon, A. Bella, N. Bogdanovic, B. Milenkovic, D. Pesut, L. Borderias, N.M.B. Garcia, H. Cabello Alarcon, C. Cilloniz, A. Torres, V. Diaz-Brito, X. Casas, A.E. Gonzalez, M.L. Fernandez-Almira, M. Gallego, I. Gaspar-Garcia, J.G.D. Castillo, P.J. Victoria, E. Laserna Martinez, R.M.D. Molina, P.J. Marcos, R. Menendez, A. Pando-Sandoval, C.P. Aymerich, J. Rello, S. Moyano, F. Sanz, O. Sibila, A. Rodrigo-Troyano, J. Sole-Violan, A. Uranga, J.F.M. van Boven, E.V. Torra, J.A. Pujol, C. Feldman, H.K. Yum, A.A. Fiogbe, F. Yangui, S. Bilaceroglu, L. Dalar, U. Yilmaz, A. Bogomolov, N. Elahi, D.J. Dhasmana, A. Feneley, C. Hancock, A.T. Hill, B. Rudran, S. Ruiz-Buitrago, M. Campbell, P. Whitaker, A. Youzguin, A. Singanayagam, K.S. Allen, V. Brito, J. Dietz, C.E. Dysart, S.M. Kellie, R.A. Franco-Sadud, G. Meier, M. Gaga, T.L. Holland, S.P. Bergin, F. Kheir, M. Landmeier, M. Lois, G.B. Nair, H. Patel, K. Reyes, W. Rodriguez-Cintron, S. Saito, N.J. Soni, J. Noda, C.I. Hinojosa, S.M. Levine, L.F. Angel, A. Anzueto, K.S. Whitlow, J. Hipskind, K. Sukhija, V. Totten, R.G. Wunderink, R.D. Shah, K.J. Mateyo, L. Noriega, E. Alvarado, M. Aman, L. Labra. - In: RESPIROLOGY. - ISSN 1440-1843. - (2019). [Epub ahead of print]
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia
S. AlibertiSecondo
Conceptualization
;M. Carrabba;
2019
Abstract
Background and objective Enterobacteriaceae (EB) spp. family is known to include potentially multidrug-resistant (MDR) microorganisms, and remains as an important cause of community-acquired pneumonia (CAP) associated with high mortality. The aim of this study was to determine the prevalence and specific risk factors associated with EB and MDR-EB in a cohort of hospitalized adults with CAP. Methods We performed a multinational, point-prevalence study of adult patients hospitalized with CAP. MDR-EB was defined when >= 3 antimicrobial classes were identified as non-susceptible. Risk factors assessment was also performed for patients with EB and MDR-EB infection. Results Of the 3193 patients enrolled with CAP, 197 (6%) had a positive culture with EB. Fifty-one percent (n = 100) of EB were resistant to at least one antibiotic and 19% (n = 38) had MDR-EB. The most commonly EB identified were Klebsiella pneumoniae (n = 111, 56%) and Escherichia coli (n = 56, 28%). The risk factors that were independently associated with EB CAP were male gender, severe CAP, underweight (body mass index (BMI) < 18.5) and prior extended-spectrum beta-lactamase (ESBL) infection. Additionally, prior ESBL infection, being underweight, cardiovascular diseases and hospitalization in the last 12 months were independently associated with MDR-EB CAP. Conclusion This study of adults hospitalized with CAP found a prevalence of EB of 6% and MDR-EB of 1.2%, respectively. The presence of specific risk factors, such as prior ESBL infection and being underweight, should raise the clinical suspicion for EB and MDR-EB in patients hospitalized with CAP.File | Dimensione | Formato | |
---|---|---|---|
Villafuerte_et_al-2019-Respirology.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.6 MB
Formato
Adobe PDF
|
1.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.